Together, these studies implicated LEDGF/p75 in cervical cancer progression and provided the foundations for the development of novel treatment strategies targeting this oncoprotein to decrease cervical tumor growth and chemoresistance. This evidence concerns the gene PSIP1 and cervical carcinoma.